Survivorship and Quality of Life in Endometrial Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Survivorship and Quality of Life".
Deadline for manuscript submissions: 30 June 2025 | Viewed by 79
Special Issue Editors
Interests: gynaecological oncology; endometrial and cervical cancer
Interests: minimal access surgery; surgical radicality and morbidity; follow-up strategies
Special Issues, Collections and Topics in MDPI journals
Interests: gynaecological cancers (endometrial, cervical, ovarian, vulvo-vaginal, minimal access surgery (robotic and laparoscopic), radical and exenterative surgery)
Interests: endometrium-cervix and vulva cancer
Special Issue Information
Dear Colleagues,
Endometrial cancer (EC) incidence is rapidly rising, especially in high- and middle-income countries. Over 400,000 cases were diagnosed globally in 2022, ranking EC at 15th amongst all cancers. At the same time, more than 300,000 patients are surviving EC annually, since mortality has steadily been decreasing for decades where access to healthcare is available. A substantial amount of new evidence is gradually altering the landscape in the management of EC. The addition of novel systemic treatments have recently proven their survival benefit in specific subtypes of advanced and recurrent disease, where prognosis used to be dismal. While the efficacy of multiple modes of cancer treatments is the main focus of research, the overall and mainly long-term impact of these treatments in patients’ quality of life is usually neglected. With an expected increasing number of EC survivors and available combinations of treatment options, research should focus on producing evidence which promotes patient quality of life.
In this Special Issue, we invite research articles and reviews on the essential elements required to promote quality of life throughout the EC patients’ journey.
Dr. George Koukourakis
Dr. Antonios Anagnostopoulos
Dr. Georgios Angelopoulos
Dr. Anthi Miliadou
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- endometrial cancer
- quality of life
- survivorship
